
J Neuropsychiatry Clin Neurosci 19:441-448, November 2007
doi: 10.1176/appi.neuropsych.19.4.441
© 2007 American Neuropsychiatric Association
Psychopathology in Verified Huntingtons Disease Gene Carriers
E. van Duijn, M.D.,
E.M. Kingma, M.Sc., M.phil. and
R.C. van der Mast, M.D., Ph.D.
Received July 15, 2006; revised November 27, 2006; accepted January 18, 2007. The authors are affiliated with Leiden University Medical Center, Department of Psychiatry, Leiden, the Netherlands. Dr. van Duijn is also affiliated with the Center for Mental Health Care Duin-en Bollenstreek, Rivierduinen, Voorhout, the Netherlands. Address correspondence to Dr. van Duijn, Leiden University Medical Center, Department of Psychiatry, B1-P, PO Box 9600, 2300 RC Leiden, the Netherlands; e.van_duijn{at}lumc.nl (e-mail).
Huntingtons disease is characterized by motor, cognitive, and neuropsychiatric symptoms. This study reviews original research on psychopathology in Huntingtons disease that uses standardized instruments in verified gene carriers. Frequently reported neuropsychiatric symptoms are depressed mood, anxiety, irritability, and apathy, with prevalences of 33% to 76%. Obsessive-compulsive symptoms and psychosis occur less often with prevalences of 10% to 52% and 3% to 11%, respectively. Available research provides little insight into the true prevalences of psychopathology in Huntingtons disease due to small sample sizes, use of different methodologies, and lack of comparison groups. Future research requires larger cohorts stratified to disease stage, consistent methodologies, and adequate comparison groups.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|